Heat therapy for lung cancer: early trial ends early

NCT ID NCT04889989

Terminated Disease control Sponsor: Ethicon, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at using a microwave ablation device to destroy lung tumors in people who could not have surgery or chose not to. It included 13 adults with non-small cell lung cancer or tumors that had spread to the lung. The treatment was given through a needle inserted into the chest. The study was stopped early, so the results are not conclusive.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: microwave ablation (a device that uses heat to destroy tumors)
What this could lead to: If successful, this approach could offer a less invasive option for people with lung cancer who cannot undergo surgery.
What could go wrong: The study was terminated early and enrolled only 13 people, so results are very limited. Microwave ablation may not fully destroy all tumor cells, and risks include bleeding or damage to nearby tissue.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER OF THE LUNG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung carcinoma lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER OF THE LUNG

Contacts and locations

Locations

Beijing Hospital

Beijing, China
Fudan University Shanghai Cancer Hospital

Shanghai, China
Henan Cancer Hospital

Henan, China
Hunan Cancer Hospital

Hunan, China
Pecking University Shenzhen Hospital

Beijing, China
Qilu Hospital of Shandong University

Shandong, China
The First Affiliated Hospital of Fujian Medical University

Fujian, China
The Fourth Affiliated Hospital of Harbin Medical University

Harbin, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.